Skip to main content
Discover what's not being covered
Get Started
SubscribeLogin
Published • loading... • Updated

Moderna (NASDAQ:MRNA) Stock Price Expected to Rise, Morgan Stanley Analyst Says

Summary by MarketBeat
Morgan Stanley boosted their price objective on shares of Moderna from $89.00 to $95.00 and gave the stock an "equal weight" rating in a report on Wednesday.

1 Articles

MarketBeatMarketBeat
Center

Moderna (NASDAQ:MRNA) Stock Price Expected to Rise, Morgan Stanley Analyst Says

Morgan Stanley boosted their price objective on shares of Moderna from $89.00 to $95.00 and gave the stock an "equal weight" rating in a report on Wednesday.

·Sioux Falls, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Wednesday, October 7, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Morgan Stanley icon

Morgan Stanley

Stock Markets icon

Stock Markets

Moderna icon

Moderna

Tarrytown icon

Tarrytown

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal